VIVIMEDLAB
vs
B
BSE Sensex 30
VIVIMEDLAB
Over the past 12 months, VIVIMEDLAB has underperformed BSE Sensex 30, delivering a return of 0% compared to the BSE Sensex 30's 1% drop.
Stocks Performance
VIVIMEDLAB vs BSE Sensex 30
Performance Gap
VIVIMEDLAB vs BSE Sensex 30
Performance By Year
VIVIMEDLAB vs BSE Sensex 30
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Vivimed Labs Ltd
Glance View
Vivimed Labs Ltd. engages in the manufacture and market of active ingredients, which are used in home and personal care products and industrial care products. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2005-08-13. The company operates in two segments: Specialty Chemicals Business and Pharma Business. The company serves various companies through the contract manufacturing (CMO) division, which offers a range of products, such as capsules and tablets, syrups and liquids, and nasal sprays and ointments. The active ingredients manufactured by the Company are used in home and personal care segments, such as hair, skin, oral care and anti-microbial preservatives. Its products include DICLOFENAC GEL BP, LULICONAZOLE CREAM, PERMETHRIN LOTION, and CLOTRIMAZOLE VAGINAL GEL. Its subsidiaries include Finoso Pharma Private Limited, Vivimed Specialty Chemicals Private Limited, Vivimed Holdings Limited, and Vivimed Labs USA INC.
